| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/33836626_HAS_TOPIC_C0003253> <https://research.tib.eu/covid-19/entity/33836626_HAS_TOPIC_C0013185> <https://research.tib.eu/covid-19/entity/33836626_HAS_TOPIC_C0018724> <https://research.tib.eu/covid-19/entity/33836626_HAS_TOPIC_C0018759> <https://research.tib.eu/covid-19/entity/33836626_HAS_TOPIC_C0031928> <https://research.tib.eu/covid-19/entity/33836626_HAS_TOPIC_C0079272> <https://research.tib.eu/covid-19/entity/33836626_HAS_TOPIC_C0079618> <https://research.tib.eu/covid-19/entity/33836626_HAS_TOPIC_C0079920> <https://research.tib.eu/covid-19/entity/33836626_HAS_TOPIC_C0079921> <https://research.tib.eu/covid-19/entity/33836626_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/33836626_HAS_TOPIC_C1704312> <https://research.tib.eu/covid-19/entity/33836626_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/33836626_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/33836626_HAS_TOPIC_C5244032> <https://research.tib.eu/covid-19/entity/33836626_HAS_TOPIC_C5244064> <https://research.tib.eu/covid-19/entity/33836626_HAS_TOPIC_C5392141> <https://research.tib.eu/covid-19/entity/33836626_HAS_TOPIC_C5392165> <https://research.tib.eu/covid-19/entity/33836626_HAS_TOPIC_C5392882>
?:authorAffiliation	[\'Human Pharma Medicine, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany.\', \'HP Country Pharmacovigilance, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany.\', \'Human Pharmacology Centre, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.\', \'Global Patient Advocacy Relations, Boehringer Ingelheim International GmbH, Ingelheim, Germany.\', \'Biostatistics and Data Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.\', \'Non-clinical Statistics, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany.\', \'Translational Medicine and Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.\', \'Occupational Health and Medical Services, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany.\', \'New Biological Entities, Boehringer Ingelheim Animal Health France SCS, Saint-Priest, France.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Baum_Patrick> <https://research.tib.eu/covid-19/entity/Boos_Bertram> <https://research.tib.eu/covid-19/entity/Eschenfelder_Christoph_C> <https://research.tib.eu/covid-19/entity/Kallsen_Kimberley> <https://research.tib.eu/covid-19/entity/Keller_Christoph> <https://research.tib.eu/covid-19/entity/M%C3%BCller_Hanns_Walter> <https://research.tib.eu/covid-19/entity/Mahmoudi_Mazyar> <https://research.tib.eu/covid-19/entity/Moroni-Zentgraf_Petra_C> <https://research.tib.eu/covid-19/entity/Mundt_Egbert> <https://research.tib.eu/covid-19/entity/Schneider_Michael> <https://research.tib.eu/covid-19/entity/Sigmund_Ralf>
?:doi	<https://research.tib.eu/covid-19/entity/10.1080/03007995.2021.1914943>
?:doi	10.1080/03007995.2021.1914943
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article>
?:journal	Current medical research and opinion
is ?:pmid of	<https://research.tib.eu/covid-19/entity/33836626>
?:pmid	<https://research.tib.eu/covid-19/entity/33836626>
?:pmid	33836626
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	0.944
?:rankingScore_hIndex	96
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C0262926_PROCESS_OF_C1527116>
?:title	Pilot study of an occupational healthcare program to assess the SARS-CoV-2 infection and immune status of employees in a large pharmaceutical company.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Property

Value

is ?:annotates of

?:authorAffiliation

[\'Human Pharma Medicine, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany.\', \'HP Country Pharmacovigilance, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany.\', \'Human Pharmacology Centre, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.\', \'Global Patient Advocacy Relations, Boehringer Ingelheim International GmbH, Ingelheim, Germany.\', \'Biostatistics and Data Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.\', \'Non-clinical Statistics, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany.\', \'Translational Medicine and Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.\', \'Occupational Health and Medical Services, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany.\', \'New Biological Entities, Boehringer Ingelheim Animal Health France SCS, Saint-Priest, France.\']

?:citedBy

-1

?:creator

?:doi

<https://research.tib.eu/covid-19/entity/10.1080/03007995.2021.1914943>

?:doi

10.1080/03007995.2021.1914943

?:hasPublicationType

<https://research.tib.eu/covid-19/entity/Journal_Article>

?:journal

Current medical research and opinion

is ?:pmid of

<https://research.tib.eu/covid-19/entity/33836626>

?:pmid

<https://research.tib.eu/covid-19/entity/33836626>

?:pmid

33836626

?:publication_isRelatedTo_Disease

<https://research.tib.eu/covid-19/entity/Covid-19>

?:rankingScore_SJR

0.944

?:rankingScore_hIndex

is ?:relation_isRelatedTo_publication of

<https://research.tib.eu/covid-19/entity/C0262926_PROCESS_OF_C1527116>

?:title

Pilot study of an occupational healthcare program to assess the SARS-CoV-2 infection and immune status of employees in a large pharmaceutical company.

?:type

?:year

2021

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/33836626>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/33836626>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

Metadata